Aziz Abu-Saleh

Aziz obtained his B.Sc. and M.Sc. degrees from Jordan before pursuing his Ph.D. at Memorial University in Canada. As a curious chemist, he is interested in leveraging computational and theoretical tools for drug design and development. As a postdoctoral fellow at the University of Windsor, his research focuses on GPCR proteins, particularly serotonin receptors, alongside other promising targets for cancer and COVID-19 treatments. Additionally, he specializes in big data preprocessing and machine learning for various drug discovery projects. With over 16 research articles and co-authorship of three patent applications, Aziz is dedicated to advancing pharmaceutical science and fostering innovation.